Moalli, Pamela A.
Bowen, Shaniel T.
Abramowitch, Steven D.
Lockhart, Mark E.
Ham, Michael
Hahn, Michael
Weidner, Alison C.
Richter, Holly E.
Rardin, Charles R.
Komesu, Yuko M.
Harvie, Heidi S.
Ridgeway, Beri M.
Mazloomdoost, Donna
Shaffer, Amanda
Gantz, Marie G.
,
Funding for this research was provided by:
National Institute of Biomedical Imaging and Bioengineering (5T32EB003392-13)
Boston Scientific Corporation
Eunice Kennedy Shriver National Institute of Child Health and Human Development (U10 HD054214, U10 HD041267, U10 HD041261, U10 HD069013, U10 HD069025, U10 HD069010, U10 HD069006, U10 HD054215, U01 HD069031)
Article History
Received: 28 May 2020
Accepted: 19 August 2020
First Online: 1 September 2020
Compliance with ethical standards
:
: Pamela A. Moalli: Amphora Medical Inc., consulting; NICHD, research support;Shaniel T. Bowen: None.Steven D. Abramowitch: NICHD: research support;Mark E. Lockhart: JUM, deputy editor, salary and editorial work; Elsevier, book royalties; Oxford Publishers, book royalties;Michael Ham: None.Michael E. Hahn: General Electric, research grant; HealthLytix, consultant;Alison C. Weidner: OBGYN Survey, assistant editor, salary and editorial work; NICHD, research support; Urocure, consultant.Holly E. Richter: IUJ, OG, editorial work and travel reimbursement; Worldwide Fistula Fund, board membership and travel reimbursement; American Urogynecologic Society, Board of Directors, travel reimbursement; Bluewind, DSMB; Renovia, Allergan, NICHD, NIA, research support; UpToDate, licensor and royalties;Charles R. Rardin: FPMRS, editorial board membership; Solace Therapeutics, Pelvalon, Foundation for Female Health Awareness, NICHD, research support;Yuko M. Komesu: Cook-Myosite®, funding; NICHD, funding.Heidi S. Harvie: None.Beri M. Ridgeway: Coloplast Corp, consulting, education, and travel & lodging;Donna Mazloomdoost: Boston Scientific, research grant.Amanda Shaffer: None.Marie G. Gantz: Boston Scientific, research grant.